Label: CLEARASIL STUBBORN ACNE CONTROL 5IN1 SPOT TREATMENT- benzoyl peroxide cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 18, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Benzoyl peroxide 10%

  • Purpose

    Acne medication

  • Use

    for the treatment of acne

  • Warnings

    For external use only

    Do not useif you

    • have very sensitive skin
    • are sensitive to benzoyl peroxide

    When using this product

    • avoid unnecessary sun exposure and use a sunscreen
    • avoid contact with the eyes, lips and mouth
    • avoid contact with hair and dyed fabrics, which may be bleached by this product
    • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
    • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.

    Stop use and ask a doctor ifirritation becomes severe

    Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • clean the skin thoroughly before applying this product
    • cover the entire affected area with a thin layer one to three times daily
    • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
    • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
    • if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
  • Other information

    • keep outer box for full product information
    • keep tightly closed
    • store at 20-25 °C (68-77 °F)
  • Inactive ingredients

    Water, Propylene Glycol, Aluminum Hydroxide, Bentonite, Glyceryl Stearate SE, PEG-12, Isopropyl Myristate, Methylparaben, Carbomer, Potassium Hydroxide, Propylparaben

  • Questions?

    1-866-25-CLEAR (1-866-252-5327).You may also report side effects to this phone number.

  • SPL UNCLASSIFIED SECTION

    Distributed By:
    RB Health (US),
    Parsippany, NJ 07054-0224

  • PRINCIPAL DISPLAY PANEL - 28 g Tube Carton

    Clearasil ®

    STUBBORN ACNE CONTROL
    5IN1 SPOT TREATMENT CREAM

    Benzoyl Peroxide Acne Medication

    FIGHTS
    5
    STUBBORN
    ACNE
    PROBLEMS

    MAXIMUM STRENGTH

    FIGHTS 1. BLOCKED PORES 2. PIMPLE SIZE
    3. EXCESS OIL 4. ACNE MARKS 5. BLACKHEADS

    Net wt. 1 oz (28 g)

    Principal Display Panel - 28 g Tube Carton
  • INGREDIENTS AND APPEARANCE
    CLEARASIL STUBBORN ACNE CONTROL 5IN1 SPOT TREATMENT 
    benzoyl peroxide cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-438
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE10 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    BENTONITE (UNII: A3N5ZCN45C)  
    GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
    POLYETHYLENE GLYCOL 600 (UNII: NL4J9F21N9)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63824-438-011 in 1 CARTON12/06/2017
    128 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00612/06/2017
    Labeler - RB Health (US) LLC (081049410)